SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - North America EU edition | APAC edition

Products > On-Demand Supplier Webinar

UC-II: A Game-Changing Ingredient for the Joint Health Category

Format: Webinar | Document type: Supplier Webinar
Related applications: Bone & joint health
Bone and Joint Health online event 2016

UC-II® is a novel patented form of undenatured type II collagen derived from chicken sternum cartilage. Since its initial discovery, InterHealth has continued to systematically build scientific support surrounding this ingredient. UC-II has undergone rigorous third-party research and testing for efficacy, safety and quality. Three randomized, double-blind, controlled trials (RCTs) show that 40 mg of UC-II once-a-day supports joint comfort, mobility and flexibility. To the best of our knowledge, UC-II is the only joint health ingredient that has been tested in healthy active exercising adults, which provides additional substantiation for its joint health benefits. UC-II is a FDA-notified and published new dietary ingredient (NDI). This presentation will discuss the results from the two recently completed RDBPC trials conducted in healthy as well as in knee OA subjects. The webinar will also highlight on how UC-II is impacting the growth of the top brands in the joint health segment.

Speakers:

  • James Lugo PhD

    James Lugo PhD

    Chief Scientific Officer

    InterHealth Nutraceuticals, Inc

  • Pat McCullough

    Pat McCullough

    Chief Commercial Officer

    InterHealth Nutraceuticals, Inc

LATEST CONTENT FROM InterHealth Nutraceuticals, Inc.

How IRI scan data show UC-II can drive joint health supplement growth

Joint relief has traditionally been a profitability powerhouse, but recently the sector has slumped. Now, data suggest its salvation may lie in an ingredient: UC-II.

Supplier's Info Centre

InterHealth